Done sou Salè H1B

Akèy › Kat vèt › Ultragenyx Pharmaceutical, Inc.

Ultragenyx Pharmaceutical, Inc.: sponso kat vèt (PERM)

Ultragenyx Pharmaceutical, Inc. te depoze 6 aplikasyon sètifikasyon travay PERM ki te pran desizyon pandan ane fiskal 2024–2026; sètifye: 5. Mwayèn salè yo ofri $212,695; mwayèn tan soti nan depozisyon jiska sètifikasyon: 471 jou.

Aplikasyon PERM6
Sètifye5
Salè medyan ofri$212,695
Mwayèn jou pou sètifikasyon471
Deja ap travay pou anplwayè a100%
Anplwaye (jan yo depoze)1,147
Nan biznis depi2010
Adrès anplwayèNovato, CA

Salè H-1B nan Ultragenyx Pharmaceutical, Inc. →

Tit travay

Tit travayAplikasyon PERMSalè medyan
Manager - Regulatory Affairs, CMC1$271,606
Manager, Quality Systems - Quality Assurance1$139,050
Senior Process Engineer, MS&T - Gene Therapy1$146,205
Associate Director/Director - Program Management Office1$258,669
Director, Quality Control Chemistry1$212,695
Associate Director, Regulatory Affairs1—

Kote travay

Okipasyon

Dènye desizyon

Tit travaySalè bazKoteSoumètDesideEstatiJou
Director, Quality Control Chemistry$212,695Woburn, MAOct 15, 2024Mar 24, 2026Sètifye525
Senior Process Engineer, MS&T - Gene Therapy$146,205Bedford, MAMay 23, 2024Sep 6, 2025Sètifye471
Manager, Quality Systems - Quality Assurance$139,050Bedford, MAMay 23, 2024Sep 6, 2025Sètifye471
Manager - Regulatory Affairs, CMC$271,606Brisbane, CAApr 22, 2024Aug 4, 2025Sètifye469
Associate Director/Director - Program Management Office$258,669Novato, CAAug 14, 2023Nov 24, 2024Sètifye, ekspiré468
Associate Director, Regulatory Affairs$222,602Novato, CAJul 11, 2023Apr 15, 2024Retire—

Salè yo se pi ba nivo salè yo ofri nan chak aplikasyon, konvèti an yon montan anyèl; estatistik yo itilize aplikasyon plen tan ki sètifye. Sètifikasyon PERM se yon etap nan direksyon yon kat vèt; USCIS pran desizyon sou petisyon an. Se pa konsèy legal. Sous: Depatman Travay Etazini, Done Divilgasyon OFLC PERM, ane fiskal 2024–2026 (dènye desizyon Jun 30, 2026).